Contact

We're here
when you need us.

Questions about your medication, order, or treatment plan — we've got you. Email us and we'll respond within 1 business day.

How to reach us.

Choose the right contact for your question. All emails are monitored by real people — no ticket queues, no bots.

Patient Support

For questions about your prescription, order status, medication shipping, or your patient account.

support@pureforty.com

Response within 1 business day. Support hours: Mon–Fri, 9am–6pm ET.

Provider Questions

For clinical questions about your treatment plan, dosage, or medication concerns — reach your provider directly through your patient portal after enrollment.

Clinical questions are handled securely through the provider messaging platform, not by email.

General Inquiries

For press inquiries, partnership opportunities, or questions that don't fit the above categories.

hello@pureforty.com

We respond to all general inquiries within 2–3 business days.

Coming Soon

Live chat is on the way.

We're setting up real-time live chat powered by Intercom. In the meantime, email us at support@pureforty.com and we'll respond within 1 business day. No ticket numbers, no runaround — just a real reply.

When we're available.

Support Hours

Monday – Friday
9:00 am – 6:00 pm ET

Response Time

Email: within 1 business day
Urgent clinical messages: same day (via patient portal)

Medical Emergencies

PureForty is a telehealth platform, not an emergency care provider. For any medical emergency, call 911 or go to your nearest emergency room immediately.

Weekends & Holidays

Support is not available on weekends or US federal holidays. Messages sent outside support hours will be answered the next business day.

Start your plan.
Free to apply.

Have more questions? Browse the FAQ or email us. Ready to get started? Complete your intake below.

See If You Qualify

Not all applicants will be approved. Compounded drug products are not FDA-approved and have not been evaluated for safety, effectiveness, or quality by the FDA.